EYPT Dividend: EyePoint Pharmaceuticals Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	42	43	46	41	36	34
Revenue Growth (YoY)	-7%	-7%	12%	14%	6%	70%
Cost of Revenue	2	3	4	8	8	5
Gross Profit	39	39	41	33	28	28
Selling, General & Admin	56	55	51	60	53	45
Research & Development	201	130	64	49	28	17
Operating Expenses	258	185	116	112	84	65
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-205	-130	-70	-102	-58	-45
Income Tax Expense	0	0	0	--	--	--
Net Income	-205	-130	-70	-102	-58	-45
Net Income Growth	99%	86%	-31%	76%	28.99%	-20%
Shares Outstanding (Diluted)	70.16	56.29	38.9	37.32	28.76	12.84
Shares Change (YoY)	28.99%	45%	4%	30%	124%	23%
EPS (Diluted)	-2.93	-2.32	-1.81	-2.74	-2.03	-3.54
EPS Growth	54%	28%	-34%	35%	-43%	-35%
Free Cash Flow	-213	-130	-1	-67	-50	-14
Free Cash Flow Per Share	-3.03	-2.3	-0.02	-1.79	-1.73	-1.09
Gross Margin	92.85%	90.69%	89.13%	80.48%	77.77%	82.35%
Operating Margin	-519.04%	-337.2%	-163.04%	-190.24%	-152.77%	-105.88%
Profit Margin	-488.09%	-302.32%	-152.17%	-248.78%	-161.11%	-132.35%
Free Cash Flow Margin	-507.14%	-302.32%	-2.17%	-163.41%	-138.88%	-41.17%
EBITDA	-216	-144	-75	-76	-53	-34
EBITDA Margin	-514.28%	-334.88%	-163.04%	-185.36%	-147.22%	-100%
D&A For EBITDA	2	1	0	2	2	2
EBIT	-218	-145	-75	-78	-55	-36
EBIT Margin	-519.04%	-337.2%	-163.04%	-190.24%	-152.77%	-105.88%
Effective Tax Rate	0%	0%	0%	--	--	--

EyePoint Pharmaceuticals Inc (EYPT) Price